- Home
- NBTX vs RELL Comparison
NBTX vs RELL Comparison
Compare NBTX & RELL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBTX
- RELL
- Stock Information
- Founded
- NBTX 2003
- RELL 1947
- Country
- NBTX France
- RELL United States
- Employees
- NBTX N/A
- RELL N/A
- Industry
- NBTX Biotechnology: Pharmaceutical Preparations
- RELL Electronic Components
- Sector
- NBTX Health Care
- RELL Technology
- Exchange
- NBTX Nasdaq
- RELL Nasdaq
- Market Cap
- NBTX 201.9M
- RELL 193.5M
- IPO Year
- NBTX 2020
- RELL N/A
- Fundamental
- Price
- NBTX $3.25
- RELL $13.69
- Analyst Decision
- NBTX Strong Buy
- RELL
- Analyst Count
- NBTX 1
- RELL 0
- Target Price
- NBTX $12.00
- RELL N/A
- AVG Volume (30 Days)
- NBTX 42.0K
- RELL 65.2K
- Earning Date
- NBTX 09-18-2024
- RELL 01-07-2025
- Dividend Yield
- NBTX N/A
- RELL 1.77%
- EPS Growth
- NBTX N/A
- RELL N/A
- EPS
- NBTX N/A
- RELL 0.03
- Revenue
- NBTX $45,220,186.00
- RELL $202,965,000.00
- Revenue This Year
- NBTX N/A
- RELL $15.51
- Revenue Next Year
- NBTX N/A
- RELL $11.28
- P/E Ratio
- NBTX N/A
- RELL $421.53
- Revenue Growth
- NBTX 526.17
- RELL N/A
- 52 Week Low
- NBTX $2.76
- RELL $8.08
- 52 Week High
- NBTX $8.43
- RELL $15.51
- Technical
- Relative Strength Index (RSI)
- NBTX 56.43
- RELL 49.35
- Support Level
- NBTX $2.85
- RELL $12.23
- Resistance Level
- NBTX $3.07
- RELL $15.38
- Average True Range (ATR)
- NBTX 0.16
- RELL 0.53
- MACD
- NBTX 0.05
- RELL -0.03
- Stochastic Oscillator
- NBTX 73.67
- RELL 46.35
About NBTX Nanobiotix S.A.
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.
About RELL Richardson Electronics Ltd.
Richardson Electronics Ltd provides engineered solutions, power grid, and microwave tubes and related consumables, power conversion, RF and microwave components, high-value flat panel detector solutions, replacement parts, tubes, and service training for diagnostic imaging equipment and customized display solutions. Its products have applications in alternative energy, healthcare, aviation, broadcast, communications, industrial, marine, medical, military, scientific, and semiconductor markets. The company segments include PMT (Power and Microwave Technologies Group), Canvys, (Green Energy Solutions) GES, and Healthcare reportable segments. The company derives the majority of its revenues from the PMT segment.